Live feed16:45:00·87dPRReleasevia QuantisnowREPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSISByQuantisnow·Wall Street's wire, on your screen.AMGN· Amgen Inc.Health Care
